Selected research
Industry Research
Inhalation Anesthetic Industry Research Report 2026
Market perspective
The global Inhalation Anesthetic market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhalation Anesthetic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhalation Anesthetic is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inhalation Anesthetic is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhalation Anesthetic include Mylan, Hengrui, Baxter Healthcare, AstraZeneca, Piramal Healthcare, Nhwa, Maruishi, Lunan and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhalation Anesthetic market in terms of revenue (US$ million) and, where applicable, sales volume (W Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhalation Anesthetic Market by Company
Mylan
Hengrui
Baxter Healthcare
AstraZeneca
Piramal Healthcare
Nhwa
Maruishi
Lunan
Hikma Pharmaceuticals
Fresenius-Kabi
Deltasorb Technologies (Blue Zone Technology)
Braun
BbVie Laboratories
Anesthesia Reclamation
Inhalation Anesthetic Segment by Type
Desflurane
Sevoflurane
Isoflurane
Others
Inhalation Anesthetic Segment by Application
Hospital Use
Clinic Use
Inhalation Anesthetic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthetic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthetic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthetic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhalation Anesthetic manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhalation Anesthetic by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhalation Anesthetic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Desflurane
- Sevoflurane
- Isoflurane
- Others
Applications
- Hospital Use
- Clinic Use
Companies covered
- Mylan
- Hengrui
- Baxter Healthcare
- AstraZeneca
- Piramal Healthcare
- Nhwa
- Maruishi
- Lunan
- Hikma Pharmaceuticals
- Fresenius-Kabi
- Deltasorb Technologies (Blue Zone Technology)
- Braun
- BbVie Laboratories
- Anesthesia Reclamation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inhalation Anesthetic Market Size (2021-2032)
- 2.2.2 Global Inhalation Anesthetic Sales (2021-2032)
- 2.2.3 Global Inhalation Anesthetic Market Average Price (2021-2032)
- 2.3 Inhalation Anesthetic by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Desflurane
- 2.3.3 Sevoflurane
- 2.3.4 Isoflurane
- 2.3.5 Others
- 2.4 Inhalation Anesthetic by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Use
- 2.4.3 Clinic Use
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inhalation Anesthetic Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inhalation Anesthetic Sales (W Tons) of Manufacturers (2021-2026)
- 3.3 Global Inhalation Anesthetic Revenue of Manufacturers (2021-2026)
- 3.4 Global Inhalation Anesthetic Average Price by Manufacturers (2021-2026)
- 3.5 Global Inhalation Anesthetic Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inhalation Anesthetic, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inhalation Anesthetic, Product Type & Application
- 3.8 Global Manufacturers of Inhalation Anesthetic, Established Date
- 3.9 Global Inhalation Anesthetic Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mylan
- 4.1.1 Mylan Company Information
- 4.1.2 Mylan Business Overview
- 4.1.3 Mylan Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Mylan Inhalation Anesthetic Product Portfolio
- 4.1.5 Mylan Recent Developments
- 4.2 Hengrui
- 4.2.1 Hengrui Company Information
- 4.2.2 Hengrui Business Overview
- 4.2.3 Hengrui Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hengrui Inhalation Anesthetic Product Portfolio
- 4.2.5 Hengrui Recent Developments
- 4.3 Baxter Healthcare
- 4.3.1 Baxter Healthcare Company Information
- 4.3.2 Baxter Healthcare Business Overview
- 4.3.3 Baxter Healthcare Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Baxter Healthcare Inhalation Anesthetic Product Portfolio
- 4.3.5 Baxter Healthcare Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Inhalation Anesthetic Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 Piramal Healthcare
- 4.5.1 Piramal Healthcare Company Information
- 4.5.2 Piramal Healthcare Business Overview
- 4.5.3 Piramal Healthcare Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Piramal Healthcare Inhalation Anesthetic Product Portfolio
- 4.5.5 Piramal Healthcare Recent Developments
- 4.6 Nhwa
- 4.6.1 Nhwa Company Information
- 4.6.2 Nhwa Business Overview
- 4.6.3 Nhwa Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nhwa Inhalation Anesthetic Product Portfolio
- 4.6.5 Nhwa Recent Developments
- 4.7 Maruishi
- 4.7.1 Maruishi Company Information
- 4.7.2 Maruishi Business Overview
- 4.7.3 Maruishi Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Maruishi Inhalation Anesthetic Product Portfolio
- 4.7.5 Maruishi Recent Developments
- 4.8 Lunan
- 4.8.1 Lunan Company Information
- 4.8.2 Lunan Business Overview
- 4.8.3 Lunan Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Lunan Inhalation Anesthetic Product Portfolio
- 4.8.5 Lunan Recent Developments
- 4.9 Hikma Pharmaceuticals
- 4.9.1 Hikma Pharmaceuticals Company Information
- 4.9.2 Hikma Pharmaceuticals Business Overview
- 4.9.3 Hikma Pharmaceuticals Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hikma Pharmaceuticals Inhalation Anesthetic Product Portfolio
- 4.9.5 Hikma Pharmaceuticals Recent Developments
- 4.10 Fresenius-Kabi
- 4.10.1 Fresenius-Kabi Company Information
- 4.10.2 Fresenius-Kabi Business Overview
- 4.10.3 Fresenius-Kabi Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Fresenius-Kabi Inhalation Anesthetic Product Portfolio
- 4.10.5 Fresenius-Kabi Recent Developments
- 4.11 Deltasorb Technologies (Blue Zone Technology)
- 4.11.1 Deltasorb Technologies (Blue Zone Technology) Company Information
- 4.11.2 Deltasorb Technologies (Blue Zone Technology) Business Overview
- 4.11.3 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Deltasorb Technologies (Blue Zone Technology) Inhalation Anesthetic Product Portfolio
- 4.11.5 Deltasorb Technologies (Blue Zone Technology) Recent Developments
- 4.12 Braun
- 4.12.1 Braun Company Information
- 4.12.2 Braun Business Overview
- 4.12.3 Braun Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Braun Inhalation Anesthetic Product Portfolio
- 4.12.5 Braun Recent Developments
- 4.13 BbVie Laboratories
- 4.13.1 BbVie Laboratories Company Information
- 4.13.2 BbVie Laboratories Business Overview
- 4.13.3 BbVie Laboratories Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 BbVie Laboratories Inhalation Anesthetic Product Portfolio
- 4.13.5 BbVie Laboratories Recent Developments
- 4.14 Anesthesia Reclamation
- 4.14.1 Anesthesia Reclamation Company Information
- 4.14.2 Anesthesia Reclamation Business Overview
- 4.14.3 Anesthesia Reclamation Inhalation Anesthetic Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Anesthesia Reclamation Inhalation Anesthetic Product Portfolio
- 4.14.5 Anesthesia Reclamation Recent Developments
5 Global Inhalation Anesthetic Market Scenario by Region
- 5.1 Global Inhalation Anesthetic Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inhalation Anesthetic Sales by Region: 2021-2032
- 5.2.1 Global Inhalation Anesthetic Sales by Region: 2021-2026
- 5.2.2 Global Inhalation Anesthetic Sales by Region: 2027-2032
- 5.3 Global Inhalation Anesthetic Revenue by Region: 2021-2032
- 5.3.1 Global Inhalation Anesthetic Revenue by Region: 2021-2026
- 5.3.2 Global Inhalation Anesthetic Revenue by Region: 2027-2032
- 5.4 North America Inhalation Anesthetic Market Facts & Figures by Country
- 5.4.1 North America Inhalation Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inhalation Anesthetic Sales by Country (2021-2032)
- 5.4.3 North America Inhalation Anesthetic Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Inhalation Anesthetic Market Facts & Figures by Country
- 5.5.1 Europe Inhalation Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inhalation Anesthetic Sales by Country (2021-2032)
- 5.5.3 Europe Inhalation Anesthetic Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Inhalation Anesthetic Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inhalation Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inhalation Anesthetic Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inhalation Anesthetic Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inhalation Anesthetic Market Facts & Figures by Country
- 5.7.1 South America Inhalation Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inhalation Anesthetic Sales by Country (2021-2032)
- 5.7.3 South America Inhalation Anesthetic Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Inhalation Anesthetic Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inhalation Anesthetic Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inhalation Anesthetic Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inhalation Anesthetic Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Inhalation Anesthetic Sales by Type (2021-2032)
- 6.1.1 Global Inhalation Anesthetic Sales by Type (2021-2032) & (W Tons)
- 6.1.2 Global Inhalation Anesthetic Sales Market Share by Type (2021-2032)
- 6.2 Global Inhalation Anesthetic Revenue by Type (2021-2032)
- 6.2.1 Global Inhalation Anesthetic Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inhalation Anesthetic Revenue Market Share by Type (2021-2032)
- 6.3 Global Inhalation Anesthetic Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inhalation Anesthetic Sales by Application (2021-2032)
- 7.1.1 Global Inhalation Anesthetic Sales by Application (2021-2032) & (W Tons)
- 7.1.2 Global Inhalation Anesthetic Sales Market Share by Application (2021-2032)
- 7.2 Global Inhalation Anesthetic Revenue by Application (2021-2032)
- 7.2.1 Global Inhalation Anesthetic Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inhalation Anesthetic Revenue Market Share by Application (2021-2032)
- 7.3 Global Inhalation Anesthetic Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inhalation Anesthetic Value Chain Analysis
- 8.1.1 Inhalation Anesthetic Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inhalation Anesthetic Production Mode & Process
- 8.2 Inhalation Anesthetic Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inhalation Anesthetic Distributors
- 8.2.3 Inhalation Anesthetic Customers
9 Global Inhalation Anesthetic Analyzing Market Dynamics
- 9.1 Inhalation Anesthetic Industry Trends
- 9.2 Inhalation Anesthetic Industry Drivers
- 9.3 Inhalation Anesthetic Industry Opportunities and Challenges
- 9.4 Inhalation Anesthetic Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst